You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTS Sale Disclosure
Czibere Akos · SEC Form 4 · Filed Jul 10, 2026
Sale
Calculated transaction value
$401.48K
Czibere Akos Chief Medical Officer
AKTS
Aktis Oncology, Inc.
AKTS
Transaction date
Jul 8, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 2 days later
AKTS daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 14,800 shares @ $27.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-300162
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$1.64M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aktis Oncology, Inc. AKTS | Exercise | Jul 8, 2026 | $247.5K |
| Aktis Oncology, Inc. AKTS Current | Sale | Jul 8, 2026 | $401.48K |
| Aktis Oncology, Inc. AKTS | Sale | Jul 8, 2026 | $861.74K |
| Aktis Oncology, Inc. AKTS | Sale | Jul 8, 2026 | $125.48K |
| Aktis Oncology, Inc. AKTS | Exercise | Jul 8, 2026 | $0 |